Literature DB >> 19657726

Decreased p21 expression in HPV-18 positive cervical carcinomas.

Lee-Wen Huang1, Kok-Min Seow, Chin-Cheng Lee, Yu-Hung Lin, Hun-Shan Pan, Heng-Ju Chen.   

Abstract

The aim of this study was to investigate the relationship between different human papillomavirus (HPV) genotypes and the expression of p53, p21 and p27 in cervical carcinomas. A total of 103 cases of cervical carcinomas were assayed for expression of p53, p21 and p27 by immunohistochemistry. HPV typing was carried out by two polymerase chain reaction-based methods. Overall, HPV prevalence was 97.1% among the cervical carcinomas in this study. HPV-16 was detected in 66% of the tumors, HPV-18 in 7.8%, HPV-16/18 in 7.8% and other HPV types in 15.5%. The expression of p53 and p27 was not related to HPV genotype. However, in the HPV-18 positive cervical carcinomas, expression of p21 was significantly decreased or completely absent (P = 0.019). Our results indicated that down-regulation of p21 was strongly associated with HPV-18 positive cervical carcinomas. The significantly lower expression of p21 protein in HPV-18 positive samples compared to HPV-18 negative cervical carcinomas supports the hypothesis that inactivation and degradation of p21 proteins by HPV-18 E7 may play an important role in the carcinogenesis of HPV-18 positive cervical neoplasia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19657726     DOI: 10.1007/s12253-009-9191-8

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  33 in total

1.  p53-independent expression of p21waf1/cip1 in preinvasive and invasive squamous neoplasms of the uterine cervix.

Authors:  B A Werness; H Q Wang; J Chance; D J Goldstein
Journal:  Mod Pathol       Date:  1997-06       Impact factor: 7.842

2.  Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein.

Authors:  J O Funk; S Waga; J B Harry; E Espling; B Stillman; D A Galloway
Journal:  Genes Dev       Date:  1997-08-15       Impact factor: 11.361

3.  Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein.

Authors:  K Zerfass-Thome; W Zwerschke; B Mannhardt; R Tindle; J W Botz; P Jansen-Dürr
Journal:  Oncogene       Date:  1996-12-05       Impact factor: 9.867

4.  p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome.

Authors:  L W Huang; Y Y Chou; S L Chao; T J Chen; T T Lee
Journal:  Gynecol Oncol       Date:  2001-11       Impact factor: 5.482

5.  Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors.

Authors:  K Nakayama; N Ishida; M Shirane; A Inomata; T Inoue; N Shishido; I Horii; D Y Loh; K Nakayama
Journal:  Cell       Date:  1996-05-31       Impact factor: 41.582

6.  Tumor suppression by p21WAF1.

Authors:  Y Q Chen; S C Cipriano; J M Arenkiel; F R Miller
Journal:  Cancer Res       Date:  1995-10-15       Impact factor: 12.701

7.  Down-regulation of p27 is associated with malignant transformation and aggressive phenotype of cervical neoplasms.

Authors:  Lee-Wen Huang; Shiouh-Lirng Chao; Jiann-Loung Hwang; Yuh-Yu Chou
Journal:  Gynecol Oncol       Date:  2002-06       Impact factor: 5.482

8.  Human papillomavirus type 18 and rapidly progressing cervical intraepithelial neoplasia.

Authors:  Ciaran B J Woodman; Stuart Collins; Terry P Rollason; Heather Winter; Andrew Bailey; Marie Yates; Lawrence S Young
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

9.  Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma.

Authors:  M Ogawa; K Maeda; N Onoda; Y S Chung; M Sowa
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  p22/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis.

Authors:  K M Ropponen; J K Kellokoski; P K Lipponen; T Pietiläinen; M J Eskelinen; E M Alhava; V M Kosma
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

View more
  3 in total

1.  P21 and p27 Immunoexpression in Upper Urinary Tract Urothelial Carcinomas.

Authors:  Banu Sarsik; Basak Doganavsargil; Adnan Simsir; Ayse Yazici; Burcin Pehlivanoglu; Cag Cal; Sait Sen
Journal:  Pathol Oncol Res       Date:  2016-05-24       Impact factor: 3.201

2.  Association between p21 Ser31Arg polymorphism and cancer risk: a meta-analysis.

Authors:  Hongxia Ma; Ziyuan Zhou; Sheng Wei; Qingyi Wei
Journal:  Chin J Cancer       Date:  2011-04

3.  Delineation of the HPV11E6 and HPV18E6 Pathways in Initiating Cellular Transformation.

Authors:  Lamech M Mwapagha; Nicki Tiffin; M Iqbal Parker
Journal:  Front Oncol       Date:  2017-11-01       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.